We are live on ! Find out more
KALA icon

KALA BIO

29 hedge funds and large institutions have $1.58M invested in KALA BIO in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

32% more funds holding

Funds holding: 2229 (+7)

0.08% more ownership

Funds ownership: 0.5%0.58% (+0.08%)

41% less capital invested

Capital invested by funds: $2.69M → $1.58M (-$1.11M)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
29
Holders Change
+7
Holders Change %
+31.82%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
3
Reduced
6
Closed
4
Calls
Puts
Net Calls
Net Calls Change

KALA Hedge Fund Activity: Q4 2025 in Review

29 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2025, worth a combined $1.58M — down 41% from $2.69M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new KALA positions and 4 closed out — a net gain of 7 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $733K. The largest seller was Vanguard Group, cutting an estimated $107K.

  • 29 institutional investors held KALA BIO (KALA) as of Q4 2025, up from 22 in Q3 2025.
  • Funds reported $1.58M of KALA BIO stock for Q4 2025, down 41% quarter-over-quarter.
  • 11 funds opened new KALA BIO positions in Q4 2025 and 4 closed out, a net change of +7 holders.
  • The largest KALA BIO buyer in Q4 2025 was Baker Bros. Advisors, an estimated $733K added.
  • The largest KALA BIO seller in Q4 2025 was Vanguard Group, an estimated $107K sold.

Based on aggregated 13F filings for Q4 2025.